chugai pharmaceutical co ltd
(4519:Tokyo Stock Exchange)
Last --
Change Today 0.00 / 0.00%
Volume 0.0
4519 On Other Exchanges
4519 is not on other exchanges.
Symbol
Exchange
All times are local (Market data is delayed by at least 15 minutes).
Executive Profile*
Yasuo IkedaDirector, Chugai Pharmaceutical Co. Ltd. |
| Age | Total Calculated Compensation | This person is connected to 22 board members in 1 different organizations across 1 different industries. See Board Relationships |
| -- | -- |
Background*
Dr. Yasuo Ikeda serves as a Professor of Department of Life Science and Medical Bioscience of Graduate School of Advanced Science and Engineering of Faculty of Science and Engineering of Waseda University. Dr. Ikeda serves as Director at Chugai Pharmaceutical Co. Ltd.
Corporate Headquarters*1-1 Nihonbashi-muromachi 2-chomeTokyo, -- 103-8324 Japan Phone: 81 3 3281 6611 Fax: 81 3 3281 2828 Board Members Memberships*Director
Education*There is no Education data available.Other Affiliations*There is no Company Affiliations data available. |
Annual Compensation*There is no Annual Compensation data available.Stock Options*There is no Stock Options data available.Total Compensation*There is no Total Compensation data available. |
*Data is at least as current as the most recent Definitive Proxy.
| Recently Viewed | |||
| 4519:JP | ¥2,254.00 JPY | -45.00 |  |
COMPETITOR COMPENSATION
| Name | Position/ Company | Compensation |
| Robert A. Bradway | Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee Amgen Inc. | $1.3M |
| Robert J. Hugin MBA | Chairman, Chief Executive Officer, President and Chairman of Executive Committee Celgene Corporation | $1.2M |
| Haruo Naito | Chief Executive Officer, President and Director Eisai Co., Ltd. | -- |
| F. Michael Ball | Chief Executive Officer, Director and Member of Science, Technology & Quality Committee Hospira Inc. | $993.3K |
| Daniel J. Abdun-Nabi | Chief Executive Officer, President, Director and Member of Strategic Operations Committee Emergent BioSolutions, Inc. | $860.3K | Compensation as of Fiscal Year 2012. |
Post a JobJobs
- Orlando, FL | Consult SoftPosted: May 22
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
Sponsored Financial Commentaries
Sponsored Links
Report Data Issue
To contact CHUGAI PHARMACEUTICAL CO LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Please enter your information in the following field(s):
Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
